Clinical trial
Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis
NCT05619302 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- January 3, 2023
- Completion date
- December 31, 2026
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac amyloidosis